Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...

Recipe collection If you’ve got the olive oil and a few other basics, we’ve got the bright, beaut Jessica Brook recipes to see you through the week without breaking a sweat. 10 recipes ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. The potential of ...

TMC the metals company is pursuing speculative and technologically unproven deep-sea nodule mining. The company's SPAC launch did not generate significant capital, and the company currently has ...

Melissa Clark’s meatball recipe is, as the name indicates, wholly versatile, and a reader favorite with five stars and over 4,000 reviews. Stuff leftovers into split hero rolls for sandwiches ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

Troopers said the cause of the crash is under investigation. He was booked in the Choctaw County Jail on several charges including felony eluding. Saturday night, the Ada Police Department ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...